Navigation Links
Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
Date:4/20/2011

apacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation affecting pharmaceutical pricing and reimbursement. Government and others' regulations and reimbursement policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
2. Amgen to Webcast 2011 Business Review Meeting on April 21
3. Amgen Announces Webcast of 2011 First Quarter Financial Results
4. Amgen Establishes Commercial Operations in Brazil
5. Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe
6. Amgen Donates $1 Million to Help Japanese Disaster Victims
7. Amgen Completes Acquisition of BioVex
8. NBPTS and Amgen Foundation Join to Bolster Science Education
9. Amgen to Present at the Citi 2011 Global Healthcare Conference
10. CURE Magazine Teams Up With Amgen Oncology and Breakaway from Cancer® to Launch 2011 Extraordinary Healer Award for Oncology Nursing
11. Boehringer Ingelheim to Purchase Amgens Fremont (USA) Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Agreement reinforces ... treatments   ViiV Healthcare and Desano ... production in China of dolutegravir. The ... pharmaceutical ingredient (API), and will allow ViiV Healthcare to offer ... under the name Tivicay®) for China ...
(Date:7/1/2015)... 1, 2015 Eli Lilly and Company (NYSE: ... quarter of 2015 on Thursday, July 23, 2015. Lilly will ... investment community and media to further detail the company,s financial ... a.m. EDT. Investors, media and the general public can access ... that will be posted on Lilly,s website at www.lilly.com ...
(Date:7/1/2015)... ISELIN, N.J. , July 1, 2015 /PRNewswire/ ... medical device company focused on non-invasive continuous glucose ... of its new and completely re-designed corporate website ... and intuitive access to Echo,s technology and enhances ... The new website better communicates to prospective ...
Breaking Medicine Technology:ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... today announced that they will welcome four new members to their industry leading ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... as organically raised chickens and eggs. Eating organic foods and products can help ... and more environmentally friendly than production chicken farming. Choosing home raised chickens and ...
(Date:7/1/2015)... ... 01, 2015 , ... The Collaborative for Children and Families (CCF) announced that ... will allow CCF to improve quality of care and save costs for the child ... to many changes in New York’s Medicaid system. Experts agree that children need thorough ...
(Date:7/1/2015)... York, NY (PRWEB) , ... July 01, 2015 , ... ... longer taboo with teenagers to fix noses and chins with plastic surgery when they’re ... Reconstructive Surgeons (ASPS) more than 236,000 cosmetic procedures were performed on patients ages 19 ...
(Date:7/1/2015)... ... ... The 28th annual Charity Horse Show hosted by the Mid-South Horse Show Association ... Pugh Bourne Park, 343 Oakfield Road. The event will again benefit Youth Town. , ... silent auction and concessions. , Horses and riders from around the country will participate ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3
... women to suffer eyelid droop as they age, scientists have discovered. ... view photographs// of the eyes of 256 people between the ages ... age of 35, the lower eyelid started to sag, the effect ... is caused by the increased laxity of eyelid tissues with age. ...
... fare better if they kept the bed for sleep and ... study found that taking sleeping pills worked in the// short-term, ... period. , Insomnia is defined as trouble falling asleep, ... the morning without being able to get back to sleep.Less ...
... young people is leading to an alarming rise in liver ... having increased in men for some time//, Professor Liam Donaldson ... signs of permanent liver damage at an earlier age. ... liver - is irreversible, although treatment can prevent it from ...
... The armpit smells of old ladies are the latest ... they warn that those of young men may have ... effect may be due to the human ability to ... which signal aggression, reports "New Scientist" magazine. ...
... believe a common liver disease may be caused by the ... thought to affect around one in four people in developed ... is currently untreatable, and one in ten sufferers go on ... the risk that cancer will develop in the organ.The damage ...
... allergy to a common chemical found in dyes, warn scientists. ... to months of pain and discomfort. The problem is not ... which is sometimes added to make the tattoo darker. ... where it is called mehendi. Dr Bjorn Hausen, of the ...
Cached Medicine News:Health News:Cure for sleepless nights 2
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
... product line has the right product for ... and from intubated patients to patients with ... both anesthesia and critical care applications., ... protection for patients and staff members. This ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Ballard trach care HMES and filters, universal use, "Y" filter, CO 2 sampling port...
Medicine Products: